Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)

NCT01352338

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Antonius Ziekenhuis Nieuwegein Nieuwegein, Utrecht, Netherlands

UMC Utrecht Utrecht, Netherlands

VU Medical Center Amsterdam, Netherlands

View Trial Details

Completed

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

NCT01413568

Conditions: Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission, Blood Protein Disorders, +36 more
Locations: University of Kansas Cancer Center Kansas City, Kansas, United States

Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

NCT00123773

Conditions: Adnexal Diseases, Blood Protein Disorders, Cardiovascular Diseases, +37 more
Locations: Cross Cancer Institute Edmonton, Alberta, Canada

View Trial Details

Completed

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

NCT00975975

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Anemia, +47 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple Myeloma

NCT01530594

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: King Faisal Specialist Hospital &Reseach Center Riyadh, Saudi Arabia

View Trial Details

Completed

Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy

NCT01094548

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Please Contact the Merck KGaA Communication Center Darmstadt, Germany

View Trial Details

Completed

Blood and Marrow Transplant Clinical Research Network

NCT00023530

Conditions: Blood Disease, Blood Protein Disorders, Bone Marrow Diseases, +19 more
Locations: City of Hope National Medical Center Duarte, California, United States

University of California at San Diego La Jolla, California, United States

Stanford University Palo Alto, California, United States

University of Florida Gainesville, Florida, United States

View all 16 locations

View Trial Details

Completed

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma

NCT00438880

Conditions: Adult Non-Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +39 more
Locations: University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma

NCT00153933

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: H. Lee Moffitt Cancer Center Tampa, Florida, United States

Winship Cancer Center Atlanta, Georgia, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Center Boston, Massachusetts, United States

View Trial Details

Completed

Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma

NCT00458705

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Paraproteinemias

Paraproteinemias trial results

Related conditions